News
Lupin Launches Favipiravir Drug Covihalt for Treatment of Mild to Moderate COVID-19
Pharma major Lupin Limited (Lupin) announced the launch of its Favipiravir in India under the brand name Covihalt® for the treatment of mild to...
Clinical Trials
Members of the COVID R&D Alliance and Quantum Leap Healthcare Collaborative Enroll First Patients in I-SPY COVID Trial
Members of the COVID R&D Alliance AbbVie, Inc., Amgen Inc., and Takeda Pharmaceutical Co. Ltd. announced the first patients enrolled in the I-SPY COVID...
Press Releases
Sun Pharma launches FluGuard (Favipiravir) in India at Rs. 35 per tablet
Sun Pharmaceutical Industries Limited announced that it has launched FluGuard (Favipiravir 200 mg) at an economical price of Rs. 35 per tablet, for the...
News
Rigenerand commences 3D bioreactor development for cGMP extracellular vesicle exosomes (EV) production
Rigenerand SRL, the biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for regenerative medicine and oncology, announces it...
News
Kodak announces initiative to create Kodak Pharmaceuticals
Eastman Kodak Company received a $765 million loan from the United States International Development Finance Corporation (DFC) to support the launch of Kodak Pharmaceuticals,...
Packaging & Labelling
CRYOPORT Partners with MEDIPAL HOLDINGS to Bring Temperature-Controlled Supply Chain Solutions to the Japanese Market
Cryoport, Inc., a global leader in life sciences supply chain solutions, and MEDIPAL HOLDINGS CORPORATION, Japan's leading pharma wholesaler and distributor announced a multi-year...
Press Releases
Partner Therapeutics Wins $35M DoD Contract for Leukine in COVID-19
Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, anounced a $35 million milestone-based Other Transaction Agreement (OTA) with the U.S. Department of Defense (DOD)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read